Exercise dose and cognition in schizophrenia: a randomized controlled trial

Exercise dose and cognition in schizophrenia: a randomized controlled trial - Exercise dose and cognition in schizophrenia: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042448

Enrollment

Registered

2020-11-13

Start date

2020-05-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

non-exercise control 2 times/week, 12 weeks exercise dose 3 times/week, 12 weeks exercise dose 2 times/week, 24 weeks exercise dose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) diagnosed with schizophrenia based on the the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)

Exclusion criteria

Exclusion criteria: (1) a current primary DSM-5 diagnosis other than schizophrenia (2) a history of mental retardation (3) a history of neurological disorder (4) a history of significant drug or alcohol abuse (5) current risk of suicide, or a history of suicidal behavior within 6 months prior to consent (6) comorbid serious physical disorder

Design outcomes

Primary

Measure	Time frame
Cognition	—

Secondary

Measure	Time frame
Intrinsic motivation Psychiatric symptom Functioning	—

Countries

Japan

Contacts

Public ContactTakeshi Shimada

Medical Corporation Seitaikai Mental Support Soyokaze Hospital Department of Rehabilitation

ot@seitaikai.or.jp0268-35-0305

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026